DJIA 16,643.01 -11.76 -0.07%
NASDAQ 4,828.33 15.62 0.32%
S&P 500 1,988.87 1.21 0.06%
market minute promo

MannKind Corp (NASDAQ: MNKD)

company name or ticker

4 Not-Too-Scary Ways to Make Money on Biotech Stocks

Here's how you can invest in biotech without too much fear.

Yahoo Reflects No Value Other Than Alibaba - Cramer's Lightning Round (8/27/15)

'Mad Money' Lightning Round: You're OK With Yahoo! and Home Depot

MannKind: The Stock Where Tomorrow Never Arrives

Why Sanofi Deserves A Second Look

3 Reasons Why Afrezza's Launch Has Been So Disappointing

Management blames its slow start for Afrezza, the company's inhaled insulin and only approved drug, on these three factors.

What's Behind Sanofi's Afrezza Pediatric Study For MannKind?

MannKind Corporation: Afrezza Is Broadly Covered

Bull Or Bear? Biotech's Post-Earnings Buys and Sells

The breakdown on which companies' numbers are easiest to swallow.

The 3 Most Disappointing Drug Launches of All Time

Treatments with huge promise don't always pan out the way you'd expect.
See More Articles...